Results 251 to 260 of about 878,067 (286)
Some of the next articles are maybe not open access.
Pulmonary effects of marijuana inhalation
Expert Review of Respiratory Medicine, 2011Marijuana is the most commonly used illicit drug around the world. It is most often consumed through smoking, placing the respiratory system in direct contact with the toxic constituents of the drug, which are similar to those of tobacco cigarettes. However, accurate study of the adverse effects of marijuana is difficult to perform, owing to marijuana ...
Megan L, Howden, Matthew T, Naughton
openaire +2 more sources
Pulmonary Delivery of Inhalable Nanoparticles: Dry Powder Inhalers
Therapeutic Delivery, 2011Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility.
M H D Kamal, Al-Hallak +5 more
openaire +2 more sources
Pulmonary Distribution of an Inhaled Radioaerosol in Obstructive Pulmonary Disease
Radiology, 1976Pulmonary distribution of an inhaled radioaerosol was analyzed in 20 cases of chronic obstructive pulmonary disease (COPD) and 8 of other OPD. Nonciliary/ciliary partition of the distribution correlated with the severity of airway obstruction and approximated 3:1 in mild and 1:3 in very severe obstruction.
M S, Lin, D A, Goodwin
openaire +2 more sources
Inhalational Drug Delivery in Pulmonary Aspergillosis
Critical Reviews™ in Therapeutic Drug Carrier Systems, 2019Pulmonary infections have long represented one of the major threats to humans. These vary from acute to chronic conditions, depending upon the underlying disease of the airways. Pulmonary aspergillosis (PMAP) has raised vital concerns in the immunocompromised patients.
Ranjot, Kaur +6 more
openaire +2 more sources
Pulmonary oedema associated with hydrocarbon inhalation
Intensive Care Medicine, 1977A patient with gross pulmonary oedema secondary to inhalation of paint fumes is described. Treatment with mechanical ventilation and positive end expiratory pressure was required.
R D, Cane, N, Buchanan, M, Miller
openaire +2 more sources
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
New England Journal of MedicinePreclinical data indicate that inhaled treprostinil may be useful for the treatment of idiopathic pulmonary fibrosis (IPF) through an antifibrotic mechanism, a premise that is supported by clinical observation.In this phase 3, double-blind trial, we randomly assigned patients with IPF to receive inhaled treprostinil or placebo (12 breaths four times ...
Steven D. Nathan +17 more
openaire +3 more sources
Inhaled prostacyclin in the treatment of pulmonary hypertension
European Journal of Pediatrics, 1999Pulmonary hypertension can occur primarily with an unknown aetiology or secondary in association with cardiac or pulmonary disorders such as congenital diaphragmatic hernia, idiopathic respiratory distress syndrome, acute respiratory distress syndrome (ARDS), congenital heart disease with malformation of the pulmonary blood vessels, chronic obstructive
M, Max, R, Rossaint
openaire +2 more sources
INHALATION PULMONARY SCINTIPHOTOGRAPHY USING PERTECHNETATE
American Journal of Roentgenology, 1971Inhalation lung scintiphotos of good quality with a minimum of bronchial deposition have been obtained using a simple, inexpensive nebulizing system and technetium in the pertechnetate form.The method described is a rapid means of obtaining useful information regarding airway patency with no radiopharmaceutical preparation.Pertechnetate is a suitable ...
D J, Cook, H, Lander
openaire +2 more sources
A profile on inhaled treprostinil for pulmonary hypertension
Expert Review of Respiratory MedicinePulmonary hypertension (PH) remains a progressive and life-threatening disease despite advances in therapies targeting multiple signaling pathways. Prostacyclin analogues play a central role in treatment; however, systemic formulations can be limited by treatment burden and systemic adverse effects.
Karim, El-Kersh, Nafis, Shamsid-Deen
openaire +2 more sources
1995
The toxic effects of inhaling smoke were first documented following the Cleveland Clinic disaster in Ohio on 15 May 1929 and later after the Coconut Grove Nightclub Fire in Boston on 28 November 1942.
openaire +1 more source
The toxic effects of inhaling smoke were first documented following the Cleveland Clinic disaster in Ohio on 15 May 1929 and later after the Coconut Grove Nightclub Fire in Boston on 28 November 1942.
openaire +1 more source

